We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Failure to Dephosphorylate Tau Proteins Leads to Alzheimer's Disease

By Biotechdaily staff writers
Posted on 12 Aug 2003
Researchers have shown that Pin1 (prolyl isomerase) is pivotal in protecting against age-dependent neurodegeneration due to its ability to dephosphorylate tau proteins, a finding that provides insight into the pathogenesis and treatment of Alzheimer's disease and other tauopathies.

In healthy brains, tau proteins serve to assemble and support the "scaffolding” systems that give neurons their structure and function. More...
Phosphates are routinely added and removed from tau. However, in certain neurodegenerative conditions, such as Alzheimer's disease, excess phosphate molecules cause the protein to change shape and cluster into fibers that become tangled and knotted, forming rigid structures that eventually lead to the destruction of the affected neurons in certain regions of the brain, resulting in symptoms of dementia.

In a study published in the July 31, 2003, issue of Nature, investigators at Harvard Medical School (Boston, MA, USA) reported they had developed a knockout mouse lacking the gene for Pin1. These animals suffered progressive age-dependent neuropathy characterized by motor and behavioral deficits, tau hyperphosphorylation, tau filament formation and neuronal degeneration. In addition, the researchers compared Pin1 expression profiles in different brain regions of both healthy individuals and patients with Alzheimer's disease.


"Our findings showed that Pin1expression inversely correlates with neuronal vulnerability to degeneration in normal brains and with the actual formation of tangles in patients with Alzheimer's,” explained senior author Dr. Kun Ping Lu, associate professor of medicine at Harvard Medical School. "Furthermore, we found that in the Pin1 knockout mouse, the removal of the Pin1 gene alone was sufficient to cause many age-dependent neurodegenerative changes. We have now shown that Pin1 plays a pivotal role in protecting against age-dependent neurodegeneration. This makes a convincing case that this enzyme should be taken into consideration in future studies of Alzheimer's disease.”




Related Links:
Harvard Medical School

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Thyroid Test
Anti-Thyroid EIA Test
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.